• Histoplasma Antigen, CSF
  • Strata Selectâ„¢, piSwitch® CiRT for Immunotherapy Management
  • Cardiac arrest
  • Benign neoplasm of peripheral nerve
  • Triglycerides, Body Fluid
  • Ductal Carcinoma In Situ, Breast
  • Immunoglobulin Subclass IgG4
  • Cytomegalovirus (CMV) CD8 T-Cell Immune Competence, Quantitative Assessment by Flow Cytometry
  • Amyloid Beta Protein Ratio 1-42/1-40, Spinal Fluid
  • Short-Chain Acyl-CoA Dehydrogenase (SCAD) Deficiency, Genetic Mutation Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Neurofibromatosis Type 1 (NF1) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Neurofibromatosis Type 1 (NF1) Gene Mutation Analysis
Medical Test

CPT
Access to Neurofibromatosis Type 1 (NF1) Gene Mutation Analysis is restricted.